Prevalence of albuminuria and associated cardiovascular risk factors: A community cohort in Namwon City, Korea

Diabetes Research and Clinical Practice

Volumn 97, Issue 3, 2012, Pages 492-498

  Kweon, Sun Seog ^a   Shin, Min Ho ^a   Choi, Jin Su ^a   Nam, Hae Sung ^b   Lee, Young Hoon ^c   Park, Kyeong Soo ^d   Lee, Jun Young ^e   Jeong, Seul Ki ^e  

^a Chonnam National University Medical School   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

^d Seonam University   (South Korea)

^e Chonbuk National University Medical School   (South Korea)

Author keywords

Albuminuria; Korean; Prevalence; Urinary albumin to creatinine ratio

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; SEX DIFFERENCE; SOUTH KOREA; URBAN POPULATION;

ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84866538432     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.05.018     Document Type: Article

References (36)

1. WHO Global burden of disease (GBD). WHO Report; 2004.
2. Yach D., Hawkes C., Gould C.L., Hofman K.J. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004, 291:2616-2622.
3. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006, 69:2057-2063.
4. Abdelhafiz A.H., Ahmed S., El Nahas M. Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol 2011, 119(Suppl. 1):e6-e10.
5. Glassock R.J. Is the presence of microalbuminuria a relevant marker of kidney disease?. Curr Hypertens Rep 2010, 12:364-368.
6. Jessani S., Levey A.S., Chaturvedi N., Jafar T.H. High normal levels of albuminuria and risk of hypertension in Indo-Asian population. Nephrol Dial Transplant 2011.
7. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. The Lancet 2010;375:2073-81.
8. Nam H.S., Shin M.H., Zmuda J.M., Leung P.C., Barrett-Connor E., Orwoll E.S., et al. Race/ethnic differences in bone mineral densities in older men. Osteoporos Int 2010, 21:2115-2123.
9. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
10. Obrador G.T., Garcia-Garcia G., Villa A.R., Rubilar X., Olvera N., Ferreira E., et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int Suppl 2010, S2-S8.
11. Mathew T.H., Corso O., Ludlow M., Boyle A., Cass A., Chadban S.J., et al. Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney Int Suppl 2010, S9-S16.
12. Takahashi S., Okada K., Yanai M. The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period. Kidney Int Suppl 2010, S17-S23.
13. Tebbe U., Bramlage P., Thoenes M., Paar W.D., Danchin N., Volpe M., et al. Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. Swiss Med Wkly 2009, 139:473-480.
14. Pan C.Y., Ho L.T., Soegondo S., Prodjosudjadi W., Suwanwalaikorn S., Lim S.C., et al. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol Ther 2008, 10:397-403.
15. Kenealy T., Elley C.R., Collins J.F., Moyes S.A., Metcalf P.A., Drury P.L. Increased prevalence of albuminuria among non-European peoples with type 2 diabetes. Nephrol Dial Transplant 2011.
16. Weir M.R. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007, 2:581-590.
17. Hao Z., Konta T., Takasaki S., Abiko H., Ishikawa M., Takahashi T., et al. The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. Intern Med 2007, 46:341-346.
18. Coresh J., Byrd-Holt D., Astor B.C., Briggs J.P., Eggers P.W., Lacher D.A., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999-2000. J Am Soc Nephrol 2005, 16:180-188.
19. Hillege H.L., Janssen W.M.T., Bak A.A.A., Diercks G.F.H., Grobbee D.E., Crijns H.J.G.M., et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001, 249:519-526.
20. Bryson C.L., Ross H.J., Boyko E.J., Young B.A. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis 2006, 48:720-726.
21. Aaron K.J., Campbell R.C., Judd S.E., Sanders P.W., Muntner P. Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Clin Nutr 2011, 94:1071-1078.
22. Jeong S.K., Seo M.W., Kim Y.H., Kweon S.S., Nam H.S. Does waist indicate dyslipidemia better than BMI in Korean adult population?. J Korean Med Sci 2005, 20:7-12.
23. Jeong S.K., Nam H.S., Rhee J.A., Shin J.H., Kim J.M., Cho K.H. Metabolic syndrome and ALT: a community study in adult Koreans. Int J Obes Relat Metab Disord 2004, 28:1033-1038.
24. Stehouwer C.D.A., Gall M.-A., Twisk J.W.R., Knudsen E., Emeis J.J., Parving H.-H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes 2002, 51:1157-1165.
25. Ibsen H., Olsen M.H., Wachtell K., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., et al. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy?. Diabetes Care 2006, 29:595-600.
26. Nephropathy in Diabetes. Diabetes Care 2004;27:s79-83.
27. Usui T., Ninomiya T., Nagata M., Doi Y., Hata J., Fukuhara M., et al. Albuminuria as a risk factor for peripheral arterial disease in a general population. J Atheroscler Thromb 2011, 18:705-712.
28. Parving H.H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345:870-878.
29. Ibsen H., Olsen M.H., Wachtell K., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005, 45:198-202.
30. Fredrickson S.K., Ferro T.J., Schutrumpf A.C. Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care 2004, 27:1754-1755.
31. Rocco A., Heerlein K., Diedler J., Sykora M., Barrows R., Hacke W., et al. Microalbuminuria in cerebrovascular disease: a modifiable risk factor?. Int J Stroke 2010, 5:30-34.
32. Chen B., Yang D., Chen Y., Xu W., Ye B., Ni Z. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta 2010, 411:705-709.
33. Sung J.K., Kim J.Y., Youn Y.J., Lee J.W., Ahn S.G., Yoo B.S., et al. Urine albumin creatinine ratio is associated with carotid atherosclerosis in a community based cohort: atherosclerosis risk of rural area in Korean general population study. J Cardiovasc Ultrasound 2010, 18:134-138.
34. Sheng C.S., Hu B.C., Fan W.X., Zou J., Li Y., Wang J.G. Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population. Diabetol Metab Syndr 2011, 3:6.
35. Kasimay O., Sener G., Cakir B., Yuksel M., Cetinel S., Contuk G., et al. Estrogen protects against oxidative multiorgan damage in rats with chronic renal failure. Ren Fail 2009, 31:711-725.
36. Shantha G.P., Kumar A.A., Bharadhi M.K., Arthur P. Role of gender in the associations of microalbuminuria with inflammatory markers in hypertensive subjects: a cross-sectional study. Kidney Blood Press Res 2009, 32:434-439.